Moore Alison
- SEC CIK
- 0001754937
In the past year, 2 open-market sale filings worth $20.7K and no purchases.
Current role at each company
- ARTV Artiva Biotherapeutics, Inc.Directoras of Sep 14, 2026
- CDXS Codexis, Inc.President and CEOas of Feb 25, 2026
- ALLO Allogene Therapeutics, Inc.Chief Technical Officeras of Mar 24, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $20.7K
- 2 filings
- Net
- −$20.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Moore Alison as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CDXS Codexis, Inc.
President and CEO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2026 (view filing) | Feb 6 | 3 days | Moore AlisonPresident and CEO | SSale | −3.83K | $1.31 | −$5.01K | −1.5%250.5K after | |
| Oct 15, 2025 (view filing) | Oct 13 | 2 days | Moore AlisonChief Technical Officer | SSale | −6.24K | $2.51 | −$15.7K | −3.6%169.3K after |
ALLO Allogene Therapeutics, Inc.
Chief Technical Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2022 (view filing) | Mar 15 | 2 days | Moore AlisonChief Technical Officer | SSale | −8.70K | $7.63 | −$66.4K | −6.7%120.4K after |